InsiderTrades

Form 4 for MET MetLife

Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001099219-23-000076 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-02 2023-02-28+ MET SCHOCK TAMARA EVP, CAO F - Tax $71.63 -5,942 15.5K -28% -$425.6K
DM 2023-03-02 2023-02-28 MET SCHOCK TAMARA EVP, CAO A - Grant — +11.0K 12.5K +747% —
D 2023-03-02 2023-02-28 MET SCHOCK TAMARA EVP, CAO A - Grant $0.00 +6,274 6,274 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-28 F D 4,646 $71.73 16,828 D — —
2 Common Common Stock 2023-02-28 A A 8,952 — 21,474 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation.
3 Common Common Stock 2023-02-28 A A 2,092 — 12,522 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
4 Common Common Stock 2023-03-01 F D 1,296 $71.27 15,532 D — —
5 Derivative Employee Stock Options (right to buy) 2023-02-28 A A 6,274 $0.00 6,274 D $71.73 · — to 2033-02-27 6,274 Common Stock (F5) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.